Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Food and Drug Administration (FDA) approved the first generic version of Victoza (liraglutide injection) at the 18 mg/3 mL strength
These side effects and medical conditions encompass stomach paralysis, gallbladder disease, cyclic vomiting syndrome, and other stomach-related problems
GLP-1 receptor agonists were originally developed to treat type 2 diabetes, with weight loss emerging as a secondary effect that later became its own use
Studies have not revealed a significant difference, despite claims that some formssuch as sublingual tablets or liquids inserted beneath the tongue to be absorbed through the tissues of the mouthhad better absorption than conventional tablets
PMID 17872997
PMID: 22074294
US$ 29.89
US$ 23.67
US$ 26.95
US$ 22.60
